Dohmen appoints Joe Hammer to Chief Development Officer
Hammer to advance corporate vision to improve public health; grow bioscience industry in Wisconsin
MILWAUKEE, April 5, 2016 /PRNewswire/ -- Further advancing Wisconsin's commitment to growth in the bioscience sector, Dohmen today announced the appointment of Joe Hammer to Chief Development Officer (CDO), effective immediately. Hammer joins Dohmen with more than 15 years of experience at General Electric, most recently serving as Managing Director of GE Capital's Life Science Finance business.
As Dohmen's CDO, Hammer will focus on growth and innovation initiatives that advance Dohmen's vision to create a more efficient, effective and easy to use health experience.
"As a private company, Dohmen has the latitude to invest in longer-term strategies. In 2009, we imagined a new service model that more closely connected life science companies with the patients they serve. We saw the potential for a new service paradigm to emerge in response to advances in precision medicine, healthcare consumerism and empowering technology. We didn't see anyone out there with a service model that could help the industry transition to patient centricity, so we created one," said Dohmen CEO, Cynthia LaConte.
Dohmen Life Science Services (DLSS), a Dohmen holding, now provides the broadest suite of outsourced services in the industry to biopharma, medical device and rare disease companies. Today, DLSS has more than 800 employees, operates in seven states and is a trusted partner to hundreds of life science companies.
"Welcoming Joe to the team underscores our continued commitment to investing in innovation that will advance our vision," added LaConte. "With DLSS firmly rooted, we're very excited to turn our attention to growing Red Arrow Labs. Technology has incredible potential to disrupt traditional healthcare delivery models and empower consumer engagement in health."
Red Arrow Labs, another Dohmen holding, will be a near-term platform for further investment as the company looks to develop and acquire transformative software that improves human health.
"Dohmen's vision is an important one. The U.S. spends double every other country on healthcare and consistently ranks lower in outcomes. Dohmen knows how to identify emerging trends and invest in solutions that make a difference," said Joseph Hammer, CDO, Dohmen. "I'm looking forward to being part of a team that invests in improving the state of healthcare in our country and I'm proud to be part of Dohmen's tradition of innovation."
Hammer currently sits on the advisory board for the Mid-America Healthcare Venture Forum, and serves as the Board Chair of BioForward, the state's largest association of bioscience leaders in drug development, medical devices and research.
About Dohmen
Founded in 1858, Dohmen has evolved from an apothecary to a portfolio of companies, each serving a unique role in pursuit of Dohmen's vision of creating an efficient, effective and easy to use health experience. Today, we're trusted partner to hundreds of companies – from Fortune 500 to start-up – helping them find efficiencies, obtain more effective health outcomes and improve their customer experience. Learn more about the Dohmen family of companies and our commitment to positive impact at www.dohmen.com.
Contact: Sarah Zwicky
Director, Public Relations
Phone: 414.434.4691
[email protected]
Photo - http://photos.prnewswire.com/prnh/20160405/351513
Logo - http://photos.prnewswire.com/prnh/20160405/351514LOGO
SOURCE Dohmen
Share this article